An observational study in COVID-19, sponsored by University Hospital, Gentofte, Copenhagen. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-26.
Sponsored by University Hospital, Gentofte, Copenhagen · Observational
The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if echocardiography - both conventional and advanced - can be used to predict which patients will develop acute respiratory distress syndrome (ARDS) or other short-term acute complications, especially focusing on cardiovascular outcomes. In addition, using a novel technique of lung ultrasound (LUS), The investigators aim to analyze specific LUS-findings, and associate them with short-term prognosis and development of ARDS and long-term cardiovascular morbidity and mortality. In all patients included, The investigators aim to examine long-term complications at timepoints: 2, 5 and 10 years of follow-up and examine if echocardiography - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 305 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →University Hospital, Gentofte, Copenhagen is the lead sponsor of 154 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
In.patients from hospitals of the greater Copenhagen area
Exclusion Criteria:
In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 2.5 months
Incident ARDS (Adult Respiratory Distress Syndrome) and intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 2.5 months
Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 2.5 months
Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 2.5 months
Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis
Time frame: 2.5 months
Death from any cause after hospital admission with a confirmed COVID-19 diagnosis at follow-up
Time frame: 2.5 months to 10 years
Incident stroke after hospital admission with a confirmed COVID-19 diagnosis at follow-up
Time frame: 2.5 months to 10 years
Incident heart failure after hospital admission with a confirmed COVID-19 diagnosis at follow-up
Time frame: 2.5 months to 10 years
Incident myocardial infarction after hospital admission with a confirmed COVID-19 diagnosis at follow-up
Time frame: 2.5 months to 10 years
Plan to share: Undecided
This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Gentofte, Copenhagen